Total Funding
60
74
Total FundingSeries C raised
Growth Score 60 in past quarter
-1 pts
Heat Score 74 in past quarter
21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
15317
D&D Pharmatech is a pharma company that develops pharmaceuticals against metabolic diseases and fibrotic diseases.
- Viktor Roschke: Co-founder
- Kang Choon Lee: Co-founder
About the Company
D&D Pharmatech is a pharmaceutical company. It is a clinical-stage global biotech company that focuses on the development and commercialization of revolutionary medicines. It develops pharmaceuticals for metabolic diseases such as obesity, MASH, and diabetes, as well as fibrotic diseases. It conducts research on oral and long-acting therapeutic
agents based on GLP-1 class peptide drugs.
